COIRO, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 11.763
AS - Asia 10.359
EU - Europa 6.407
SA - Sud America 1.146
AF - Africa 483
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 12
AN - Antartide 1
Totale 30.193
Nazione #
US - Stati Uniti d'America 11.431
SG - Singapore 4.055
CN - Cina 2.941
VN - Vietnam 1.451
FI - Finlandia 1.264
IE - Irlanda 1.189
SE - Svezia 934
DE - Germania 929
BR - Brasile 894
HK - Hong Kong 713
UA - Ucraina 668
TR - Turchia 518
ZA - Sudafrica 386
FR - Francia 314
NL - Olanda 310
IT - Italia 300
CA - Canada 255
GB - Regno Unito 158
IN - India 145
RU - Federazione Russa 97
AR - Argentina 87
BD - Bangladesh 70
IQ - Iraq 67
PL - Polonia 45
BE - Belgio 43
MX - Messico 43
EC - Ecuador 42
PK - Pakistan 40
PH - Filippine 38
JP - Giappone 34
VE - Venezuela 32
ID - Indonesia 31
ES - Italia 28
KR - Corea 26
TH - Thailandia 26
AT - Austria 24
IR - Iran 24
SA - Arabia Saudita 23
UZ - Uzbekistan 23
CO - Colombia 22
CI - Costa d'Avorio 21
CL - Cile 21
EU - Europa 21
LT - Lituania 20
MA - Marocco 19
PY - Paraguay 17
AZ - Azerbaigian 15
KE - Kenya 15
PE - Perù 15
EG - Egitto 13
IL - Israele 11
MY - Malesia 10
TW - Taiwan 10
UY - Uruguay 10
AL - Albania 9
JO - Giordania 9
NO - Norvegia 9
AU - Australia 8
HU - Ungheria 8
KG - Kirghizistan 8
RO - Romania 8
CZ - Repubblica Ceca 7
DO - Repubblica Dominicana 7
NP - Nepal 7
OM - Oman 7
PA - Panama 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
CY - Cipro 6
KZ - Kazakistan 6
LB - Libano 6
LU - Lussemburgo 6
PS - Palestinian Territory 6
BG - Bulgaria 5
BH - Bahrain 5
JM - Giamaica 5
LK - Sri Lanka 5
PT - Portogallo 5
SN - Senegal 5
SY - Repubblica araba siriana 5
TN - Tunisia 5
HN - Honduras 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
AM - Armenia 3
AO - Angola 3
CH - Svizzera 3
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
SK - Slovacchia (Repubblica Slovacca) 3
BY - Bielorussia 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MN - Mongolia 2
ZW - Zimbabwe 2
Totale 30.165
Città #
Singapore 2.110
Ashburn 1.587
Chandler 1.396
Jacksonville 1.282
Dublin 1.186
San Jose 837
Beijing 792
Santa Clara 785
Dallas 688
Hong Kong 687
Izmir 483
Ho Chi Minh City 455
Dearborn 441
Johannesburg 371
Nanjing 361
Hanoi 352
Boardman 304
San Mateo 273
Princeton 260
Lauterbourg 228
Toronto 192
Shanghai 183
Los Angeles 180
Ann Arbor 151
Nanchang 140
Munich 139
Des Moines 136
Wilmington 131
Shenyang 126
Kunming 118
Düsseldorf 114
Helsinki 109
New York 100
Woodbridge 94
Hebei 83
São Paulo 74
Tianjin 70
Columbus 68
Haiphong 67
Jinan 64
Hefei 62
Moscow 60
Buffalo 57
Guangzhou 50
Da Nang 46
Grafing 46
Changsha 45
Parma 44
Brussels 43
Leawood 40
Turku 40
Jiaxing 39
London 34
Warsaw 34
Seattle 33
Atlanta 31
Redondo Beach 29
Chennai 28
Tokyo 28
Pune 27
Hangzhou 26
Phoenix 26
Porto Alegre 26
Zhengzhou 26
Chicago 25
Hải Dương 24
Monmouth Junction 24
Rio de Janeiro 24
Baghdad 23
Brooklyn 23
Campinas 23
Abidjan 21
Augusta 21
Denver 21
Falkenstein 21
Manchester 20
Poplar 20
Tashkent 20
Biên Hòa 19
Bremen 19
Fremont 19
Fuzhou 18
Ninh Bình 18
Nuremberg 18
Orem 18
Ardabil 17
Milan 17
Stockholm 17
Amsterdam 16
Belo Horizonte 16
Boston 16
Dhaka 16
San Francisco 16
Borås 15
Frankfurt am Main 15
Norwalk 15
Ottawa 15
Taiyuan 15
Quito 14
Brasília 13
Totale 18.809
Nome #
Different effects of aging on the opioid mechanisms controlling gonadotropin and cortisol secretion in man. 376
Effetto del trattamento idropinico con acqua sulfurea della fonte Pergoli di Tabiano nell'epatopatia cronica alcol-correlata 178
Alpha2-adrenergic and histamine H1 and H2-receptors do not mediate arginine-vasopressin release in response to insulin induced hypoglycemia in man. 171
Inhibition by somatostatin of LH-RH-induced LH release in normal menstruating women. 170
5-HT3 serotonergic receptor mediation of hypoglycemia-induced arginine-vasopressin but not oxytocin secretion in normal men. 170
Abnormal arginine vasopressin response to cigarette smoking and metoclopramide, but not insulin induced hypoglycemia in elderly subjects. 166
Inhibitory effect of somatostatin on the NPY response to insulin-induced hypoglycemia and the role of endogenous opioids 165
5HT1-, but not 5HT2- serotonergic or M1-, M2-muscarinic cholinergic or dopaminergic receptors mediate the ACTH/cortisol response to metoclopramide. 163
Effetto coleretico e colagogo dell'acqua sulfureo-solfato calcica di Tabiano sulla colestasi nell'epatopatia alcool-correlata 162
Different effect of metoclopramide and domperidone on GH release in type 1 male diabetics. 162
Abnormal growth hormone and cortisol but not thyroid stimulating hormone response to an intravenous glucose tolerance test in normal weight bulimic women. 162
Abnormal arginine vasopressin responses to metoclopramide and insulin induced hypoglycemia in type I diabetes mellitus. 160
Abnormal plasma oxytocin and b-endorphin levels in alcoholics after short and long-term abstinence. 160
: Beta-endorphin, ACTH and cortisol secretion rhythms in abstinent alcoholics. 160
ADRENOCORTICOTROPIC HORMONE/CORTISOL RESPONSE TO PHYSICAL EXERCISE IN ABSTINENT ALCOHOLIC PATIENTS 160
Naloxone decreases the inhibitory effect of somatostatin on GH release induced by cigarette smoking in man 158
Effect of muscarinic and nicotinic-cholinergic blockade on the glucagon response to insulin-induced hypoglycemia in normal men. 157
Oxytocin reduces angiotensin II-induced ACTH release in men. 156
Diurnal variation of plasma ACTH, Cortisol and beta-endorphin levels in cocaine addicts 155
Arginine vasopressin secretion in non obese women with polycystic ovary syndrome. 155
Alterazione del controllo oppioide delle gonadotropine, ma non del cortisolo nell'uomo anziano. 155
Glucagon response to insulin-induced hypoglycemia in obese men. 154
Dopaminergic, but not cholinergic involvement in regulation of hypoglycemia-induced oxytocin release in man. 153
ACTH and Beta-Endorphin responses to physical exercise in adolescent women tested for anxiety and frustration 152
Oxytocin administration does not alter growth hormone response to insulin induced hypoglycemia in normal men. 152
Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorders. 152
The growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics involves a cholinergic mechanism. 151
Age-related decreased in the opioid control of LH secretion during reproductive years in normal men. 151
The infusion of somatostatin reduces the arginine vasopressin response to insulin induced hypoglycemia in man. 151
Age-related changed in growth hormone (GH) secretion in normally cycling women. 150
: Evaluation of bone metabolism regulating hormones during treatment with salty bromo iodic baths in menopausal women. 150
GLUCORECEPTORS LOCATED IN THE BRAIN MEDIATE NPY RELEASE INDUCED BY HYPOGLICEMIA IN NORMAL MEN 149
Lysine-vasopressin inhibits the effect of oxytocin on the insulin response to glucose in normal man. 149
Alcoholism abolishes the gamma-aminobutyric acid (GABA)ergic control of GH secretion in humans. 147
Alterata risposta secretiva del GH allo stimolo GABAergico nel morbo di Parkinson. 147
Different effects of baclofen on LH and cortisol responses to naloxone in normal men. 146
Histaminergic H1 and H2 receptors do not mediate cortisol release in response to naloxone in normal men. 145
Effect of oxytocin on growth hormone (GH) secretion in response to arginin-vasopressin. 144
Effect of serotonergic system on AVP secretion induced by physical exercise 144
Effect of potentiation of cholinergic tone by pyridostigmine on the growth hormone (GH) response to GH-releasing hormone in elderly men. 143
Iperresponsività nell'anziano dell'arginin-vasopressina a stimolazione con fumo di sigaretta o con metoclopramide, ma non con ipoglicemia insulinica. 142
Stimulatory effect of naloxone on plasma cortical in humans: possible direct stimulatory action at the adrenal cortex. 141
Effect of lysine vasopressin on basal and TRH stimulated TSH and PRL release in normal men. 141
Failure of metergoline to antagonize naloxone induced cortisol rise in man. 139
Arginine Vasopressin and Oxytocin responses to angiotensin II are mediated by AT1 receptor subtype in normal men 138
Influenza dell'età sulla responsività ipofisaria GH- e ACTH-secernente alla lisin vasopressina. 138
Oxytocin does not modify glucagon- or calcitonin induced ACTH/Cortisol rise in humans. 137
Effect of Naloxone on the LH response to intravenously-infused substance P in normal men 137
Effect of metoclopramide on serum GH levels in normal women. 137
Cholinergic- muscarinic-receptors participate in growth hormone secretion induced by lysine-8-vasopressin in man. 137
TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration. 136
Intravenously infused Substance P is unable to change basal and TRH-stimulated PRL secretion in normal men. 136
Lysine-vasopressin does not affect basal and LH-RH stimulated LH and FSH release during the menstrual cycle of normal women. 136
Effect of pharmacological doses of oxytocin on insulin response to glucose in man. 136
Increased Arginine-Vasopressin Response to Hypertonic Stimulation and Upright Posture in Idiopathic Hyperprolactinemia 135
Iperresponsività nell'anziano dell'arginin-vasopressina a stimolazione con fumo di sigaretta o con metoclopramide, ma non con ipoglicemia insulinica. 135
Abnormal effect of cigarette smoking on pituitary hormone secretions in insulin-dependent diabetes mellitus. 135
Cholinergic mediation of growth hormone secretion induced by thyrotropin-releasing hormone in cirrhotic patients. 135
Effect of naloxone on oxytocin-induced cortisol decrease in normal men. 134
Effect of histaminergic H1- and H2-receptor antagonist on neurophysin release in response to nicotine from cigarette smoking in normal men. 134
Influence of residual C-peptide secretion on the arginine-vasopressin response to hypoglycemia and metergoline in insulin-dependent diabetes. 134
Growth hormone responses to GHRH, clonidine and insulin-induced hypoglycemia in normal weight bulimic women. 134
Effect of naloxone on the inhibitory effect of melatonin on the release of arginine-vasopressin induced by physical exercise in man 133
Age-dependent decrease in the growth hormone (GH) response to GH releasing hormone in normally cicling women. 133
Nicotinic-cholinergic involvement in arginine-vasopressin response to insulin-induced hypoglycemia in normal men. 132
La somministrazione endovenosa di ossitocina non determina variazioni nelle concentrazioni di prolattina, TSH e GH in un gruppo di soggetti di sesso maschile. 132
Endogenous opioid mediation of the inhibitory effect of ethanol on the prolactin response to breast stimulation in normal women. 132
Control of oxytocin secretion in elderly men 132
Alteration in dopaminergic function in abstinent alcoholics. 132
Effect of nitric oxide on basal and TRH- or metoclopramide-stimulated prolactin release in normal men 132
Circadian vairiations in plasma ACTH, cortisol and beta-endorphin levels in normal weight bulimic women. 132
Precoce atrofia cerebrale in alcoolisti di sesso maschile: effetti dell'età e della durata dell'assunzione di alcool e del periodo di astinenza. 132
Arginine-vasopressin (AVP) responses to osmotic, pressure-volumetric and hypoglycemic stimuli in women with polycistic ovaries (PCO) 132
Reduction of lysine vasopressin induced GH, but not ACTH release in elderly men. 132
Effetti sulla tiroide dell'assunzione di iodio in corso di terapia termale a Salsomaggiore 131
Naloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercice in man 131
Effect of systemic oxytocin administration on dexamethasone-induced leptin secretion in normal and obese men. 131
Hypoglycemia induced arginine vasopressin and oxytocin release is mediated by glucoreceptors located inside the blood brain barrier 131
Effect of naloxone on neurophysin secretion in normal women. 130
Effect of cimetidine on PRL secretion in elderly subjects. 130
The gabaergic control of prolactin release is not affected by insulin-dependent diabetes mellitus: evidence from studies with sodium valproate. 130
Dopaminergic and opioid receptor antagonist do not modify the secretory response of growth hormone to lysine-vasopressin in normal subjects. 130
Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycemia in insulin-dependent diabetics. 129
Antiserotonergic and antihistaminergic agents do not antagonize naloxone-induced cortisol secretion in normal men. 127
Inhibition of growth hormone secretion in mild primary hyperparathyroidism 126
Endogenous opioids modulate the oxytocin response to insulin induced hypoglycaemia and partially mediate the inhibitory effect of ethanol in man. 126
Inhibition by oxytocin of Endothelin-1-induced ACTH secretion in normal men. 126
TSH and PRL responses to domperidone in men with insulin-dependent diabetes mellitus (IDDM) 126
Somatostatin reduces Neuropeptide Y rise induced by physical exercise. 125
Stimulatory effect of naloxone on plasma cortisol in human: possible direct stilulatory action at the adrenal cortex 125
Effetto della somministrazione di ossitocina sulla secrezione di prolattina nella donna normale. 125
Luteinizing hormone response to an intravenous infusion of substance P in normal men. 125
Oxytocin response to insulin-induced hypoglycaemia in obese subjects before and after weight loss. 125
Aspetti neuroendocrini della terapia termale: ruolo degli oppioidi nella termoregolazione. 125
Naloxone decreases the inhibiting effect of ethanol on the release of arginine-vasopressin induced by cigarette smoking in man. 124
Gabaergic mediation of the inhibitory effect of endogenous opioids on the arginine vasopressin and oxytocin responses to nicotine from cigarette smoking 124
Blunted GH response from cigarette smoking in four week abstinent alcoholics. 124
Luteinizing hormone and cortisol responses to naloxone in normal weight women with bulimia. 124
Somatostatin does not modulate arginine vasopressin and oxytocin responses to angiotensin II 123
Reduction of nomifensine-induced growth hormone release in elderly men. 123
Totale 14.340
Categoria #
all - tutte 99.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.459


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021512 0 0 0 0 0 0 0 0 0 12 479 21
2021/20221.235 6 28 7 21 35 53 183 230 61 84 77 450
2022/20234.413 490 425 289 355 343 545 19 294 1.497 22 103 31
2023/20241.499 96 198 24 44 119 265 38 366 39 30 132 148
2024/20254.953 86 307 395 246 522 710 27 209 545 464 401 1.041
2025/202610.464 1.156 906 1.423 939 1.709 776 1.283 373 1.285 614 0 0
Totale 30.218